10.75 USD
-0.3 (-2.71%)
10.75 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 81% to FULC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 19.38. This target is 80.28% above the current price.
- FULC was analyzed by 15 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about FULC.
- In the previous month the buy percentage consensus was at a similar level.
- FULC was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-01-12 | JP Morgan | Initiate | Overweight |
| 2025-12-11 | Truist Securities | Maintains | Buy -> Buy |
| 2025-12-09 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-12-08 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-12-08 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-12-08 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-12-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-24 | Truist Securities | Initiate | Buy |
| 2025-11-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-10-30 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-10-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-07-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-07-29 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2025-05-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-23 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2025-05-15 | Cantor Fitzgerald | Upgrade | Neutral -> Overweight |
| 2025-02-26 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-14 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-09-13 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-09-13 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-09-12 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-09-12 | Cantor Fitzgerald | Downgrade | Overweight -> Neutral |
| 2024-09-12 | Stifel | Downgrade | Buy -> Hold |
| 2024-09-12 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2024-09-09 | B of A Securities | Upgrade | Underperform -> Neutral |
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-05-20 | Cantor Fitzgerald | Initiate | Overweight |
FULCRUM THERAPEUTICS INC / FULC FAQ
Can you provide the average price target for FULCRUM THERAPEUTICS INC stock?
15 analysts have analysed FULC and the average price target is 19.38 USD. This implies a price increase of 80.28% is expected in the next year compared to the current price of 10.75.
What is the consensus rating for FULCRUM THERAPEUTICS INC (FULC) stock?
The consensus rating for FULCRUM THERAPEUTICS INC (FULC) is 81.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for FULCRUM THERAPEUTICS INC stock?
The number of analysts covering FULCRUM THERAPEUTICS INC (FULC) is 15.